➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
AstraZeneca
Harvard Business School
Johnson and Johnson
McKesson

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Aventis U.S. LLC v. Apotex Corp. (D. Del. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Apotex Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Sanofi-Aventis U.S. LLC v. Apotex Corp. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-09-09 107 Claim Construction Chart Chart for U.S. Patent Nos. 10,583,110 (“the ’110 patent”) and 10,716,777 (“the ’777 patent”). The…the ’110 patent. Exhibit B to the Joint Claim Construction Chart is a copy of the ’777 patent. Exhibit… ’110 Patent, Figs. 1-5 ’777 patent, Exhibit B, including…110 Patent at 2:43-3:41 Prosecution file history of the ’110 patent, … Prosecution file history of the ’777 patent, ’110 Patent at 8:61-65 Exhibit D External link to document
2020-12-01 178 13. The term “the ’110 patent” means United States Patent No. 10,583,110. …the ’777 patent” means United States Patent No. 10,716,777. 15. The term “patents-in-suit…States patent or patent application that directly or indirectly claims priority to the Patents-in-Suit…interest or right to the patents-in-suit and any product embodying any claim of the patents-in- suit. RESPONSE… any of the patents-in-suit, the infringement, validity or enforceability of those patents, or any External link to document
2021-01-04 209 Opinion - Memorandum Opinion U.S. Patent No. 10,583,110 (“the ‘110 Patent”) and U.S. Patent No. 10,716,777 (“the ‘777 Patent”). The…OPINION providing claim construction for U.S. Patent Nos. 10,583,110 and 10,716,777. Within five days the parties… defined in the ‘110 and ‘777 Patents. ‘110 Patent 11:20-22; ‘777 Patent 11:19-20. This understanding …administration of said cabazitaxel.” ‘110 Patent 18:8-18. Claim 1 of the ‘777 Patent discloses a method using a “dose…cabazitaxel.” ‘777 Patent 18: 54- 61. 1 1 Why the ‘777 Patent, which is a continuation External link to document
2021-01-10 215 Order following te1ms in U.S. Patent Nos. 10,583,110 ("the '110 patent") and 10,716,777 ("…;777 patent") are constmed as set f01ih below: Term Patent Claims…resistant metastatic prostate cancer '110 patent: claim 1 castration resistant metastatic …after or after treatment with '777 patent: claim 1 treatment with docetaxel 1 docetaxel…the a method of increasing '110 patent: claim 1 intentional pmpose of increasing External link to document
2020-06-12 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2. (myr) (Entered… 12 June 2020 1:20-cv-00804 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Dow
AstraZeneca
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.